ICH Considerations: oncolytic viruses

  • Email
  • Help
Current version

ICH Considerations

Reference numberEMEA/CHMP/ICH/607698/2008
Published21/10/2009
KeywordsGene therapy, oncolytic viruses, wild type, genetically modified oncolytic viruses, manufacture, characterisation, non-clinical, clinical, biosafety
DescriptionThis document describes the general principles for the manufacturing, characterisation, non-clinical and clinical testing of medicinal products based on oncolytic viruses.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more